Oncomine Focus Panel and PD-L1 Test sale cost 10500 AED
NGS TP53 Mutation Analysis Test sale cost 42000 AED NGS TP53 Mutation Analysis Test Cost 56,000 د.إ Original price was: 56,000 د.إ.42,000 د.إCurrent price is: 42,000 د.إ.
Oncomine Myeloid Panel MDSMPNAMLCMLCMMLJMML Test sale cost 7500 AED Oncomine Myeloid Panel MDSMPNAMLCMLCMMLJMML Test Cost 10,000 د.إ Original price was: 10,000 د.إ.7,500 د.إCurrent price is: 7,500 د.إ.
Sale!

Oncomine Focus Panel and PD-L1 Test Cost

Original price was: 14,000 د.إ.Current price is: 10,500 د.إ.

-25%

The Oncomine Focus Panel and PD-L1 Test, offered by DNA Labs UAE for a cost of 10,500 AED, represents a cutting-edge approach in the field of precision medicine, specifically designed to cater to patients with various types of cancer. This comprehensive test combines the strengths of the Oncomine Focus Panel, which utilizes next-generation sequencing technology to identify key genetic alterations across a wide array of cancer-related genes, with the PD-L1 test that measures the expression of the PD-L1 protein in cancer cells.

The Oncomine Focus Panel targets a curated list of genes associated with cancer, enabling clinicians to pinpoint specific mutations and alterations that could influence treatment decisions. By identifying these genetic markers, healthcare providers can recommend more personalized and effective therapy options for patients, such as targeted therapies or immunotherapies that are best suited to their genetic profile.

The PD-L1 test adds another layer of precision by assessing the level of PD-L1 expression, a protein that plays a crucial role in suppressing the immune response against cancer cells. High levels of PD-L1 on tumor cells may indicate that certain immunotherapies, which block the PD-L1 pathway and thus boost the immune system’s ability to fight cancer, could be particularly beneficial for the patient.

Conducted at the state-of-the-art facilities of DNA Labs UAE, this combined testing approach offers a robust tool in the personalized treatment of cancer, aiming to improve outcomes by tailoring therapies to the unique genetic makeup of each patient’s tumor.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Oncomine Focus Panel and PDL1 Test

At DNA Labs UAE, we offer the Oncomine Focus Panel and PDL1 Test for comprehensive genomic profiling of tumor samples. This next-generation sequencing (NGS) assay targets 52 genes commonly mutated in solid tumors, providing valuable information for oncology research and clinical applications.

Test Components

  • Paraffin embedded tissue blocks

Price

The cost of the Oncomine Focus Panel and PDL1 Test is 10500.0 AED.

Sample Condition

This test requires tumor tissue samples.

Report Delivery

Reports are typically delivered within 20-25 days.

Method

The Oncomine Focus Panel and PDL1 Test utilizes both next-generation sequencing (NGS) and immunohistochemistry (IHC) methods.

Test Type

This is a genetics test.

Doctor

This test is recommended for oncology patients.

Test Department

This test is conducted in our specialized genetics test department.

Pre Test Information

A prescription from a doctor is required for the Oncomine Focus Panel + PDL1 Test. However, it is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

Test Details

The Oncomine Focus Panel is specifically designed for use with formalin-fixed, paraffin-embedded (FFPE) tissue samples, which are commonly used in clinical settings. This panel targets 52 genes commonly mutated in solid tumors, providing comprehensive genomic profiling.

PDL1 (programmed death-ligand 1) is a protein expressed on the surface of some cancer cells. It helps these cells evade the immune system. PDL1 expression can be used as a biomarker to predict the response to immunotherapy drugs that block the interaction between PDL1 and its receptor on T cells. This allows the immune system to attack cancer cells.

PDL1 expression is detected using immunohistochemistry (IHC) assays on FFPE tissue samples. By combining the Oncomine Focus Panel with PDL1 IHC testing, a more comprehensive picture of the genomic and immune landscape of a tumor can be obtained. This information is crucial in guiding treatment decisions, especially for patients with advanced or metastatic cancer who may benefit from immunotherapy.

Furthermore, this approach aids researchers in understanding the mechanisms of tumor immune evasion and developing more effective immunotherapies.

Test Name Oncomine Focus Panel and PDL1 Test
Components Paraffin embedded tissue blocks
Price 10500.0 AED
Sample Condition Tumor tissue
Report Delivery 20-25 days
Method NGS,IHC
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information Oncomine Focus Panel + PDL1 can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The Oncomine Focus Panel is a next-generation sequencing (NGS) assay that targets 52 genes commonly mutated in solid tumors. It is designed to provide comprehensive genomic profiling of tumor samples for oncology research and clinical applications. The panel is optimized for use with formalin-fixed, paraffin-embedded (FFPE) tissue samples, which are commonly used in clinical settings.

PDL1 (programmed death-ligand 1) is a protein that is expressed on the surface of some cancer cells and helps them evade the immune system. PDL1 expression can be used as a biomarker to predict response to immunotherapy drugs that block the interaction between PDL1 and its receptor on T cells, allowing the immune system to attack the cancer cells. PDL1 expression can be detected using immunohistochemistry (IHC) assays on FFPE tissue samples.

Combining the Oncomine Focus Panel with PDL1 IHC testing can provide a more comprehensive picture of the genomic and immune landscape of a tumor. This information can help guide treatment decisions, particularly for patients with advanced or metastatic cancer who may benefit from immunotherapy. Additionally, this approach can enable researchers to better understand the mechanisms of tumor immune evasion and develop more effective immunotherapies.

SKU: TEST-688 Category:

Related products